Skip to main content
    A

    Amgen Inc (AMGN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $462.32
    -3.35 (-0.72%)

    Market Cap: $251.89B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Amgen Inc (AMGN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Amgen are AstraZeneca (AZN), Merck & Company (MRK) and Gilead Sciences (GILD). Amgen trades at 19.9x earnings, against a median of 21.4x for the 9 of these companies with a P/E. By market cap, Amgen ranks 6th of the 13 companies on this page; Johnson & Johnson (JNJ) is the largest at $687.89B.

    Peer Comparison

    AMGN's ROIC of 17.0% is above the peer median of 12.8%, and its revenue growth of 8.5% is above the median of 6.3%. Its dividend yield is below the peer median of 2.67%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Amgen (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    Johnson & Johnson (JNJ)$687.89B26.6x6.9x16.2%12.8%5.9%1.90%
    Peer median$196.00B21.4x4.1x14.3%12.8%6.3%2.67%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Amgen, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    AstraZeneca PLC (AZN)
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Gilead Sciences Inc (GILD)
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Novo Nordisk A/S (NVO)
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    Novartis AG ADR (NVS)
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    GSK plc (GSK)
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Biogen Inc (BIIB)
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    Johnson & Johnson (JNJ)
    Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
    JNJ competitors

    Frequently Asked Questions About AMGN

    Who are Amgen's main competitors?

    The companies most similar to Amgen include AstraZeneca (AZN), Merck & Company (MRK), Gilead Sciences (GILD), AbbVie (ABBV) and Pfizer (PFE), listed from the closest match.

    Who is Amgen's biggest competitor?

    Johnson & Johnson (JNJ) is the largest of the similar companies at $687.89B; AstraZeneca (AZN) is the closest match by business profile, size, sector and industry.

    How does AMGN stock compare with its competitors?

    AMGN's P/E is 19.9x against a peer median of 21.4x; its P/S is 6.4x against a peer median of 4.1x; its net margin is 24.1% against a peer median of 14.3%.

    Which of Amgen's competitors pays a higher dividend?

    Amgen has a forward dividend yield of 2.18%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), Novartis AG ADR (NVS), Merck & Company (MRK) and AbbVie (ABBV) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Amgen bigger than its competitors?

    No. Amgen is 6th by market cap among the 13 companies on this page; the largest is Johnson & Johnson (JNJ) at $687.89B.